Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: miRNA-106a directly targeting RARB associates with the expression of Na+/I− symporter in thyroid cancer by regulating MAPK signaling pathway

Fig. 5

a, transwell invasion assay in 8505C-miR106a(−) and control cells (*, P < 0.05); b, scratch-wound migration assay in 8505C-miR106a(−) and control cells (*, P < 0.05); c, transwell invasion assay in CGTH-W3-miR106a(+) and control cells (*, P < 0.05); d, scratch-wound migration assay in CGTH-W3-miR106a(+) and control cells (*, P < 0.05)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us